How a glass shortage could slow coronavirus vaccine development and distribution
There's more than science standing between a coronavirus vaccine and the American people.
The U.S. Heath and Human Services Department has moved to accelerate COVID-19 vaccine development, albeit separately from the rest of the world's efforts. But its eventual distribution will be hampered by an unprepared supply chain that has never had to deal with crisis of this scale before, Politico reports.
The U.S. is embarking on "Project Warp Speed" to produce a vaccine, rejecting a collaboration with the World Health Organization that could've let the U.S. access research from around the world. Taking shortcuts to speed up development is problematic in its own right, with the U.S. government giving developers permission to skip certain animal and human trials and perhaps eventually allowing the vaccine's emergency use before it's fully reviewed, Politico notes.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
After development comes the process of packaging and distributing the vaccine — and a whole host of other problems. Vaccines are packaged inside specialized glass vials, and the industry that produces that medical glass has been facing a sand shortage since before COVID-19 hit, Politico reports. Dr. Rick Bright, who was leading coronavirus vaccine development until his alleged ouster, says in his whistleblower complaint he warned of a shortage of borosilicate tubing that's needed to make vials, but his concerns were ignored.
The industries making stoppers and needles needed to contain vaccines are also ripe for shortages. Read more about the vaccine's looming supply chain problem at Politico.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
Today's political cartoons - March 8, 2025
Cartoons Saturday's cartoons - trade wars, healthcare costs, and more
By The Week US Published
-
Marbled tea eggs recipe
The Week Recommends With a beautiful exterior, these eggs are also marked by their soft yolk
By The Week UK Published
-
The Washington Post: kowtowing to Trump?
Talking Point The newspaper's opinion editor has handed in his notice following edict from Jeff Bezos
By The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published